Free Trial

Retractable Technologies (RVP) Competitors

Retractable Technologies logo
$0.78 +0.03 (+3.33%)
Closing price 08/8/2025 03:58 PM Eastern
Extended Trading
$0.78 0.00 (0.00%)
As of 08/8/2025 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RVP vs. HYPR, CTCX, ZYXI, TELA, NSPR, RBOT, MDAI, ICCM, SURG, and CTSO

Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include Hyperfine (HYPR), Carmell (CTCX), Zynex (ZYXI), TELA Bio (TELA), InspireMD (NSPR), Vicarious Surgical (RBOT), Spectral AI (MDAI), IceCure Medical (ICCM), SurgePays (SURG), and Cytosorbents (CTSO). These companies are all part of the "medical equipment" industry.

Retractable Technologies vs. Its Competitors

Retractable Technologies (NYSE:RVP) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, media sentiment, profitability, earnings, valuation, dividends and analyst recommendations.

Hyperfine has a consensus price target of $1.06, indicating a potential downside of 8.62%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts clearly believe Hyperfine is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Hyperfine
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 57.1% of Retractable Technologies shares are owned by insiders. Comparatively, 31.0% of Hyperfine shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Retractable Technologies has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Retractable Technologies$33.75M0.69-$7.01M-$0.77-1.01
Hyperfine$12.89M7.00-$40.72M-$0.54-2.15

Retractable Technologies has a net margin of -41.11% compared to Hyperfine's net margin of -343.42%. Retractable Technologies' return on equity of -17.15% beat Hyperfine's return on equity.

Company Net Margins Return on Equity Return on Assets
Retractable Technologies-41.11% -17.15% -9.33%
Hyperfine -343.42%-74.19%-62.40%

In the previous week, Hyperfine had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Hyperfine and 0 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 equaled Hyperfine'saverage media sentiment score.

Company Overall Sentiment
Retractable Technologies Neutral
Hyperfine Neutral

Retractable Technologies has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.

Summary

Retractable Technologies beats Hyperfine on 8 of the 15 factors compared between the two stocks.

Get Retractable Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVP vs. The Competition

MetricRetractable TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$23.20M$72.26M$5.51B$20.74B
Dividend YieldN/AN/A4.60%3.65%
P/E Ratio-1.449.5030.0328.06
Price / Sales0.69104.74450.3756.12
Price / Cash48.2518.4136.7723.05
Price / Book0.236.798.184.33
Net Income-$7.01M-$25.86M$3.26B$994.32M
7 Day Performance4.33%6.57%6.13%1.97%
1 Month Performance13.99%3.10%0.07%-1.60%
1 Year Performance-26.19%48.11%36.31%14.39%

Retractable Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVP
Retractable Technologies
1.6433 of 5 stars
$0.78
+3.3%
N/A-26.9%$23.20M$33.75M-1.44240Gap Down
HYPR
Hyperfine
0.7455 of 5 stars
$1.10
+1.9%
$1.06
-3.6%
+2.7%$84.06M$12.89M-2.04190Upcoming Earnings
Gap Up
CTCX
Carmell
N/A$3.88
-4.4%
N/A+157.1%$81.11M$32.84K0.0014Gap Down
ZYXI
Zynex
2.7835 of 5 stars
$2.56
-0.8%
$5.50
+114.8%
-80.9%$78.02M$192.35M-10.67770
TELA
TELA Bio
2.4937 of 5 stars
$1.90
-1.0%
$7.25
+281.6%
-57.6%$75.95M$71.22M-1.35120News Coverage
Upcoming Earnings
NSPR
InspireMD
3.6351 of 5 stars
$2.44
+0.4%
$4.50
+84.4%
-15.4%$74.75M$7.03M-3.2550
RBOT
Vicarious Surgical
1.1414 of 5 stars
$9.79
-12.7%
$8.50
-13.2%
+52.5%$66.54MN/A-0.94210Upcoming Earnings
MDAI
Spectral AI
2.294 of 5 stars
$2.75
+5.8%
$4.75
+72.7%
+61.6%$65.82M$29.58M-5.0983News Coverage
Upcoming Earnings
ICCM
IceCure Medical
2.5637 of 5 stars
$1.03
-3.7%
$2.50
+142.7%
+36.4%$62.81M$3.29M-3.6860News Coverage
Upcoming Earnings
SURG
SurgePays
3.343 of 5 stars
$2.83
-3.7%
$9.00
+218.0%
+22.2%$60.01M$60.88M-1.0140Upcoming Earnings
High Trading Volume
CTSO
Cytosorbents
1.5668 of 5 stars
$0.94
-0.2%
$5.50
+483.9%
-4.8%$59.08M$35.60M-3.36220News Coverage
Earnings Report
Analyst Forecast
Gap Up

Related Companies and Tools


This page (NYSE:RVP) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners